SOS Lab에스오에스랩
464080 · KOSDAQ · ₩464080 · 에스오에스랩
What brokers say about SOS Lab
Calculated by JONBUR from publicly available broker reports. Reports belong to their publishers. Not financial advice. Includes brokers that publish research publicly; some brokers' reports are client-only and not included.
AI summary of public information
An AI summary of the public information on this company: filed financial statements, filings, prices and news headlines. It doesn't use broker reports; their targets and estimates are shown above.
SOS Lab is growing revenue and launching new LiDAR products, but it still posts large operating losses and carries heavy debt.
SOS Lab, a Korean LiDAR sensor maker, reported trailing twelve-month revenue of about ₩5.0B against an operating loss of about ₩18.2B for the period to H1 2026. Its 2025 revenue rose 23.3% to ₩6.1B, but net losses widened to ₩17.7B, and borrowings of about ₩49.9B exceed its ₩1.9B cash. Recent filings and news centre on new smart-infrastructure and autonomous driving LiDAR products and a partnership with Semunite.
What stands out
- Trailing revenue is ₩5.0B, but operating margin is -361.7% and net margin is -388.4%, so losses are large relative to sales.
- 2025 revenue grew 23.3% to ₩6.1B, yet operating losses were about ₩16.1B that year.
- Liabilities are 391.8% of equity and trailing free cash flow was about -₩15.5B, which points to reliance on external funding.
- Shares are at ₩9,060, down 8.5% over one month and 9.4% over one year, though up 11.2% over three months and well below the 52-week high of ₩28,700.
- Recent news covers the ML-I LiDAR for smart infrastructure and a Semunite collaboration, but the data does not show revenue from these yet.
- Foreign ownership rose from 1.2% to 2.1% over 60 days, while retail investors were net sellers over the last 20 days.
What to watch
- The next quarterly and annual results, to see whether revenue growth is narrowing the operating loss.
- The conversion price adjustment filed on 2026-10-12, which may relate to convertible securities and potential dilution; the data does not give details.
- Whether the new products and the Semunite partnership produce disclosed contracts; the data does not give their size or timing.
Data as of Oct 21, 2026 · written Oct 22, 2026
This is not financial advice.
Also known as: SOS Lab / 에스오에스랩 / 464080 / KRX:464080
Source: KRX statistical information